Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, discusses how greater visual needs are contributing to adverse eye health in younger populations.
With visual needs rising substantially in recent years, eye conditions such as cataract have been shown to be more impactful at an earlier age, said Raj Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision.
Transcript
Can you speak on the growing prevalence of cataracts in younger populations?
I wouldn't say that they're necessarily being noticed at an earlier age, I think it's just more impactful at an earlier age because of our visual needs. So, certainly all of the types of conditions we've talked about that can contribute to cataracts at an earlier age, we still need to watch for.
Again, whether they're medical causes, trauma, or medications as examples, but because of our greater visual needs, we are finding that we're doing cataract surgery at an earlier age because patients’ vision is impacting their life and that's when we primarily choose to perform cataract surgery.
It’s when a patient's vision is impacting their daily functioning, and therefore then we can, by cataract surgery, remove the natural lens, the cloudy lens of the eye, and implant an intraocular lens that makes up for the power. And then we have different options in how we select those intraocular lenses and what we do in cataract surgery.
"The Barriers Are Real": Antoine Keller, MD, on Geography and Cardiovascular Health
April 18th 2025Health care disparities are often driven by where patients live, explained Antoine Keller, MD, as he discussed the complex, systematic hurdles that influence the health of rural communities.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More